Trial Outcomes & Findings for Lactose-free Milk in Infants With Acute Diarrhea in a Developing Country (NCT NCT02246010)

NCT ID: NCT02246010

Last Updated: 2019-02-15

Results Overview

number of days with 3 or more loose or watery stools

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

6 participants

Primary outcome timeframe

From onset of illness till the day of last diarrheic stool passed.

Results posted on

2019-02-15

Participant Flow

Participant milestones

Participant milestones
Measure
Lactose-free Milk
Lactose- free milk formula (Similac LF®) and anti-diarrheic diet for 7 days. Lactose- free milk: Lactose- free milk
Regular Infant Milk
Regular infant milk formula and anti-diarrheic diet for 7 days.
Overall Study
STARTED
4
2
Overall Study
COMPLETED
4
2
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Lactose-free Milk in Infants With Acute Diarrhea in a Developing Country

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Lactose-free Milk
n=4 Participants
Lactose- free milk formula (Similac LF®) and anti-diarrheic diet for 7 days.
Regular Infant Milk
n=2 Participants
Regular infant milk formula and anti-diarrheic diet for 7 days.
Total
n=6 Participants
Total of all reporting groups
Age, Customized
Less than 6 months
1 Participants
n=99 Participants
0 Participants
n=107 Participants
1 Participants
n=206 Participants
Age, Customized
Equal or more than 6 months
3 Participants
n=99 Participants
2 Participants
n=107 Participants
5 Participants
n=206 Participants
Sex: Female, Male
Female
2 Participants
n=99 Participants
1 Participants
n=107 Participants
3 Participants
n=206 Participants
Sex: Female, Male
Male
2 Participants
n=99 Participants
1 Participants
n=107 Participants
3 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
White
4 Participants
n=99 Participants
2 Participants
n=107 Participants
6 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Diarrhea duration
4.2 Days
STANDARD_DEVIATION 2.2 • n=99 Participants
3.5 Days
STANDARD_DEVIATION 0.7 • n=107 Participants
4.0 Days
STANDARD_DEVIATION 1.7 • n=206 Participants

PRIMARY outcome

Timeframe: From onset of illness till the day of last diarrheic stool passed.

number of days with 3 or more loose or watery stools

Outcome measures

Outcome measures
Measure
Lactose-free Milk
n=4 Participants
Lactose- free milk formula (Similac LF®) and anti-diarrheic diet for 7 days. Lactose- free milk: Lactose- free milk
Regular Infant Milk
n=2 Participants
Regular infant milk formula and anti-diarrheic diet for 7 days.
Diarrhea Duration
8.7 Days
Standard Deviation 2.2
8.5 Days
Standard Deviation 2.1

SECONDARY outcome

Timeframe: 7 days

Percent weight loss from baseline

Outcome measures

Outcome measures
Measure
Lactose-free Milk
n=4 Participants
Lactose- free milk formula (Similac LF®) and anti-diarrheic diet for 7 days. Lactose- free milk: Lactose- free milk
Regular Infant Milk
n=2 Participants
Regular infant milk formula and anti-diarrheic diet for 7 days.
Weight Loss
8.6 percent of body weight in kilogram
Standard Deviation 0.2
2.5 percent of body weight in kilogram
Standard Deviation 0.1

SECONDARY outcome

Timeframe: 7 days

Number of participants with illness visits

Outcome measures

Outcome measures
Measure
Lactose-free Milk
n=4 Participants
Lactose- free milk formula (Similac LF®) and anti-diarrheic diet for 7 days. Lactose- free milk: Lactose- free milk
Regular Infant Milk
n=2 Participants
Regular infant milk formula and anti-diarrheic diet for 7 days.
Illness Visits
3 Participants
1 Participants

SECONDARY outcome

Timeframe: 7 days

Rate of hospitalization

Outcome measures

Outcome measures
Measure
Lactose-free Milk
n=4 Participants
Lactose- free milk formula (Similac LF®) and anti-diarrheic diet for 7 days. Lactose- free milk: Lactose- free milk
Regular Infant Milk
n=2 Participants
Regular infant milk formula and anti-diarrheic diet for 7 days.
Hospitalization Rate
0 Participants
0 Participants

SECONDARY outcome

Timeframe: 7 days

Parental satisfaction with treatment on a Likert scale from 0 (not satisfied) to 10 (very satisfied).

Outcome measures

Outcome measures
Measure
Lactose-free Milk
n=4 Participants
Lactose- free milk formula (Similac LF®) and anti-diarrheic diet for 7 days. Lactose- free milk: Lactose- free milk
Regular Infant Milk
n=2 Participants
Regular infant milk formula and anti-diarrheic diet for 7 days.
Parental Satisfaction
7.7 units on a scale
Standard Deviation 0.6
9.5 units on a scale
Standard Deviation 0.7

Adverse Events

Lactose-free Milk

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Regular Infant Milk

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Mona Nabulsi

American University of Beirut

Phone: 9611350000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place